Altimmune Announces Second Quarter 2020 Financial Results and Provides a Business Update

NEXT STORY
Aprea Therapeutics Reports Second Quarter 2020 Financial Results and Provides Update on Business Operations
PREV STORY
HTG Molecular Diagnostics Reports Second Quarter 2020 Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Alberta Medical Association honors six Albertans for their extraordinary contributions to health care

EDMONTON, Alberta, Sept. 14, 2017 (GLOBE NEWSWIRE) -- On Friday, September 15, the Alberta ...

author_avatar
NASDAQ Market News

Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19

author_avatar
NASDAQ Market News

Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours

PRESS RELEASE Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid ...

author_avatar
NASDAQ Market News